Truvestments Capital’s Avita Medical RCEL Stock Holding History

Truvestments Capital’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-277	Closed	-$956	–	1207
2025 Q4	$956	Sell	277 -416	-60%	-$1.66K	﹤0.01%	924
2025 Q3	$3.54K	Sell	693 -553	-44%	-$2.88K	﹤0.01%	876
2025 Q2	$6.59K	Hold	1,246	–	–	﹤0.01%	702
2025 Q1	$10.1K	Sell	1,246 -155	-11%	-$1.45K	﹤0.01%	657
2024 Q4	$17.9K	Buy	1,401 +596	+74%	+$7.03K	﹤0.01%	514
2024 Q3	$8.63K	Buy	+805	New	+$7.56K	﹤0.01%	600
2024 Q2	–	Sell	-655	Closed	-$10.5K	–	574
2024 Q1	$10.5K	Hold	655	–	–	﹤0.01%	495
2023 Q4	$8.99K	Hold	655	–	–	﹤0.01%	523
2023 Q3	$9.57K	Hold	655	–	–	0.01%	457
2023 Q2	$11.1K	Hold	655	–	–	0.01%	442
2023 Q1	$9.15K	Buy	+655	New	+$6.97K	﹤0.01%	446

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Truvestments Capital's RCEL Position: Q1 2026 in Review

Truvestments Capital sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 277 shares — an estimated $956 sold.

Truvestments Capital first reported a position in RCEL in Q1 2023 and held it in 11 quarters. The position peaked at $17.9K in Q4 2024. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

Truvestments Capital reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
Truvestments Capital sold 277 Avita Medical shares in Q1 2026, an estimated $956.
Truvestments Capital first reported a position in Avita Medical in Q1 2023 and held it in 11 quarters.
Truvestments Capital's Avita Medical position peaked at $17.9K in Q4 2024.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.